Melanocortin-receptor agonist peptides — including PT-141 and Melanotan II — supplied as lyophilised powder for in vitro laboratory research. Every vial is HPLC-tested with a batch certificate in the COA library, stocked in Australia and dispatched the same business day when ordered before 12pm AEST. For in vitro research purposes only.
Melanocortin agonists are peptides that bind the melanocortin receptor family, MC1R through MC5R. This category groups PT-141, also called bremelanotide, which is used in melanocortin receptor pharmacology, and Melanotan II, an alpha-MSH analogue studied in skin pigmentation work. Australian Research Peptides lists both as freeze-dried powder, for in vitro laboratory research and no other purpose.
PT-141, or bremelanotide, is sold in Australia by Australian Research Peptides in one 10 mg vial of freeze-dried powder, and it works on desire rather than blood flow. It switches on…
Melanotan II darkens skin, and it is stocked in Australia by Australian Research Peptides in one sealed 10 mg vial of freeze-dried powder, a cyclic ring of seven amino acids. It copies…
Choose by which melanocortin receptor the published work centres on. PT-141 is studied in receptor pharmacology broadly, while Melanotan II is an alpha-MSH analogue whose literature sits in skin pigmentation. Both are supplied as a single 10 mg vial strength.
| Compound | Vial strengths listed | Studied in relation to |
|---|---|---|
| PT-141 | 10 mg | melanocortin receptor pharmacology |
| Melanotan II | 10 mg | skin pigmentation |